What is NDC 70518-3433?

70518-3433 is the product NDC for Sildenafil, Sildenafil citrate 20 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 4 package NDCs, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sildenafil?

150 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sildenafil NDC 70518-3433 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3433Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3433Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70518-3433-2	7051834330270518343302	360 POUCH in 1 BOX (70518-3433-2) / 1 TABLET in 1 POUCH (70518-3433-1)Marketed from Jun 9, 2022
70518-3433-4	7051834330470518343304	180 POUCH in 1 BOX (70518-3433-4) / 1 TABLET in 1 POUCH (70518-3433-1)Marketed from Jan 10, 2024
70518-3433-5	7051834330570518343305	100 POUCH in 1 BOX (70518-3433-5) / 1 TABLET in 1 POUCH (70518-3433-1)Marketed from Jul 8, 2026
70518-3433-6	7051834330670518343306	50 POUCH in 1 BOX (70518-3433-6) / 1 TABLET in 1 POUCH (70518-3433-1)Marketed from Jul 8, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sildenafil
Generic name (nonproprietary): sildenafil
Active ingredients: Sildenafil citrate — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210394
Marketing start: Jun 9, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 70518-3433_562d2978-ebba-15dd-e063-6294a90a0503SPL ID 562d2978-ebba-15dd-e063-6294a90a0503SPL set ID e4f41e9e-d508-4f91-8677-8a19b07139deRxCUI 577033UNII BW9B0ZE037
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518343302 followed by a unit qualifier and the quantity

Package 70518-3433-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 9, 2026.

Indications (excerpt from the label)

Adults Sildenafil tablets, USP are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies ( 14 )]. Pediatric use information is approved for Viatris Specialty LLC's, REVATIO (sildenafil) tablets. However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. Adults Sildenafil tablets are a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clin…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-3433

What is NDC 70518-3433?: 70518-3433 is the product NDC for Sildenafil, Sildenafil citrate 20 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sildenafil.
What is the active ingredient?: Sildenafil citrate.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sildenafil?: 150 other product NDCs are listed under this name. See all Sildenafil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sildenafil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sildenafil	Sildenafil citrate 25 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-434	59746-0434-0359746-0434-0459746-0434-05+2 more
Sildenafil	Sildenafil citrate 50 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-435	59746-0435-0159746-0435-0359746-0435-04+3 more
Sildenafil	Sildenafil citrate 100 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-436	59746-0436-0159746-0436-0359746-0436-04+3 more
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4596	70518-4596-00
Sildenafilsildenafil citrate	Sildenafil citrate 25 mg/1	FilmOral	Yaral Pharma Inc.	82347-0205	82347-0205-0482347-0205-0582347-0205-06
Sildenafilsildenafil citrate	Sildenafil citrate 50 mg/1	FilmOral	Yaral Pharma Inc.	82347-0210	82347-0210-0482347-0210-0582347-0210-06
Sildenafilsildenafil citrate	Sildenafil citrate 75 mg/1	FilmOral	Yaral Pharma Inc.	82347-0215	82347-0215-0482347-0215-0582347-0215-06
Sildenafilsildenafil citrate	Sildenafil citrate 100 mg/1	FilmOral	Yaral Pharma Inc.	82347-0220	82347-0220-0482347-0220-0582347-0220-06
Sildenafil	Sildenafil citrate 20 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-987	51407-0987-90
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	AvKARE	42291-937	42291-0937-90

All 151 Sildenafil NDCs

Other NDCs under ANDA 210394

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210394
Product	Strength	Form · route	Labeler	Product NDC
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-124
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2537
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2602
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-7974
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	Bryant Ranch Prepack	71335-1963
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	DirectRx	72189-298
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	Quallent Pharmaceuticals Health LLC	82009-094
Sildenafil	Sildenafil citrate 20 mg/1	TabletOral	Proficient Rx LP	82804-185